Krystal Biotech: RBC cuts target price to $375 from $400
KRYS•RBC cut its target price for Krystal Biotech to $375 from $400.
Related News
Waystar Holding Corp.: TD Cowen cuts target price to $39 from $42
WAY•
Once Upon a Farm cut to underperform from buy; price objective lowered to $10 from $21
OFRM•
Global markets were already fragile. Big AI bets could break them
SPY•
New York Times business news - November 3
AAPL•
Cohen & Steers price objective cut to $46 from $53
CNS•